Request a document copy: A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP‑DC) or with tumor lysate (OC‑DC) in patients with advanced high‑grade ovarian serous carcinoma

all files (of this document) in restricted access
the file(s) you requested
Cancel